An industry emphasis on improving inclusion and diversity in clinical trials continues to grow, but strategies to achieve more balanced representation in research and clinical care remain elusive.

Before coming to study brain tumor immunotherapy at Duke, Yang got medical training at Peking Union Medical College, founded by the Rockefeller foundation to modernize medical education in China, where he is originally from.

Two medical students begin the next chapter in their lives as MD/MEng, equipped with a unique skillset and the ability to forge collaborations between engineers and clinicians to drive innovation in healthcare.

Huang, who was recruited to Duke as a Duke Science and Technology Scholar in August of 2020, studies the development and function of cortical circuits underlying motor control and cognitive processing. He is a co-leader of a massive effort to map the brain in new detail.   

Duke researchers have shown that SARS-CoV-2 can infect kidney cells via multiple binding sites and use the cell’s machinery to replicate, causing injury and kidney disease. The discovery helps explain why acute kidney injury is one of the main complications observed in patients with severe COVID.

Four PhD students in the School of Medicine have received prestigious awards from the National Science Foundation’s Graduate Research Fellowship Program (NSF GRFP) for 2022.

Shanti Narayanasamy is conducting a mixed-methods study that uses surveys and interviews to investigate how healthcare professionals think of race and use it in their practice.

Duke in DC and Duke Health Government Relations convened a group of Duke experts to brief federal policymakers on the importance of federal investment in research, the impacts from their work, and additional recommendations to bolster our nation’s public health, medical preparedness, and response systems

Researchers have developed a novel mobile health (mHealth) tympanometer with a machine learning interface which they believe will have broad applicability and has the potential to improve diagnoses in community health settings, where access to a specialist can be limited.

The Duke Cancer Institute is excited to announce the establishment of the Duke Sarcoma Center, a center of excellence for sarcoma treatment and research.